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Abstract
Classical benzodiazepines, such as diazepam, interact with axb2c2 GABAA receptors, x = 1, 2, 3, 5 and modulate their
function. Modulation of different receptor isoforms probably results in selective behavioural effects as sedation and
anxiolysis. Knowledge of differences in the structure of the binding pocket in different receptor isoforms is of interest for the
generation of isoform-specific ligands. We studied here the interaction of the covalently reacting diazepam analogue 3-NCS
with a1S204Cb2c2, a1S205Cb2c2 and a1T206Cb2c2 and with receptors containing the homologous mutations in a2b2c2,
a3b2c2, a5b1/2c2 and a6b2c2. The interaction was studied using radioactive ligand binding and at the functional level using
electrophysiological techniques. Both strategies gave overlapping results. Our data allow conclusions about the relative
apposition of a1S204Cb2c2, a1S205Cb2c2 and a1T206Cb2c2 and homologous positions in a2, a3, a5 and a6 with C-atom
adjacent to the keto-group in diazepam. Together with similar data on the C-atom carrying Cl in diazepam, they indicate
that the architecture of the binding site for benzodiazepines differs in each GABAA receptor isoform a1b2c2, a2b2c2, a3b2c2,
a5b1/2c2 and a6b2c2.
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Introduction
Benzodiazepines are widely used drugs. They exert sedative/
hypnotic, anxiolytic, muscle relaxant, and anticonvulsant effects.
Benzodiazepines are safe and effective in short term treatments
even if some side effects as anterograde amnesia have been
reported.
Benzodiazepines act at the major inhibitory neurotransmitter
receptor, the c-aminobutyric acid type A (GABAA) receptor. The
GABAA receptors are composed of five subunits surrounding a
central chloride ion selective channel [1–4]. A variety of subunit
isoforms of the GABAA receptor has been cloned, leading to a
multiplicity of receptor subtypes [1,2,5,6]. The major receptor
isoform in mammalian brain consists of a1, b2, and c2 subunits
[6,7]. Different approaches have indicated a 2a:2b:1c subunit
stoichiometry for this receptor [8–13] with a subunit arrangement
cbaba anti-clockwise as seen from the synaptic cleft [11–13]. The
classical benzodiazepine diazepam binds with high affinity and
positively modulates recombinant a1bxc2 (x = 1, 2, 3), a2bxc2,
a3bxc2 and a5bxc2 GABAA receptors. The high affinity binding
site has been located between the a and c subunit and is
homologous to the agonist binding site located between the b and
a subunit [14,15]. Even if it is very common in the field to discuss
e.g. ‘‘a1 receptors’’, there is good evidence for the fact that many
GABAA receptors contain two different a subunit isoforms (e.g.
[16]). Exclusively the a subunit adjacent to the c subunit defines
the nature of the benzodiazepine site [17].
It has been demonstrated that the residue H101 within the a1
subunit [18] and the homologous residues a2H101, a3H126 and
a5H105 are crucial for diazepam potentiation [19]. In a4 and a6
containing receptors the homologous residue is an arginine
rendering these receptors insensitive to classical benzodiazepines
[18,20,21]. Replacement of arginine by histidine in a4 and a6
confers benzodiazepine sensitivity [18] and replacement of
histidine by arginine in a1, a2, a3 and a5 abolishes modulation
by diazepam [18,19].
Pharmacological and behavioral studies of knock-in mice in
which the relevant histidine residue has been mutated to an
arginine, have led to correlations between the a subunit isoform
adjacent to the c subunit and several of the behavioral effects
mediated by benzodiazepines. These studies have revealed that
GABAA receptors containing an a1 subunit in this position
mediate the sedative, the anterograde amnesic and partly the
anticonvulsive effects of diazepam [22,23]. GABAA receptors
containing an a2 subunit in this position mediate the anxiolytic
effect and the myorelaxant effect [24,25]. GABAA receptors
containing either an a3 or an a5 subunit adjacent to the c subunit
contribute to the myorelaxant actions of benzodiazepines
[24,26,27].
Diazepam is arranged in the binding pocket of a1b2c2
receptors such as to allow interaction of a reactive group
replacing the –Cl atom with a reactive residue in place of
a1H101 [28–31] and interaction of a reactive group attached to
the 39-atom with a reactive residues in place of a1S205 or
a1S206 [32]. It has also been shown that a reactive residue in
place of the –Cl atom interacts with a reactive residue in place
the histidine homologous to a1H101 in a2, a3 and the
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corresponding arginine residue in a6 but not to the histidine
residue in a5 [33].
In addition to the high affinity binding site for benzodiazepines,
two low affinity binding sites were identified; one has been
described to be located in the lipid bilayer [34] and the second at
the a/b subunit interface [33,35].
We used the proximity-accelerated chemical reaction approach
to further characterize the architecture of the benzodiazepine
binding site in different receptor isoforms. GABAA receptor
residues thought to reside in the site were individually mutated to
cysteine and combined with a modified benzodiazepine molecule
carrying a substituent reactive with cysteine at the 39 atom (3-
NCS, Fig. 1). Direct apposition of target carbon atom of the NCS
group and the reactive –S– group of cysteine is expected to lead to
a covalent reaction.
We studied interaction of 3-NCS compound with amino acid
residues 204, 205 and 206 in a1b2c2 receptors and the homologous
residues in a2b2c2, a3b2c2, a5b1/2c2 and a6b2c2 (Fig. 2), using
radioactive ligand binding studies at receptors expressed in HEK-
cells and electrophysiological studies, using the two electrode
voltage clamp technique at receptors expressed in Xenopus laevis
oocytes. In each receptor isoform axb2c2 (x = 1, 2, 3, 5, 6), we
found a different interaction pattern of the corresponding a
subunit with the cysteine reactive compound. This indicates a
difference in shape of the benzodiazepine binding site in the region
of the 39 atom of diazepam in different receptor isoforms. We
further observed disruption of benzodiazepine binding site in
a1G207Cb2c2 and a2G207Cb2c2 receptors.
Methods
Construction of the Mutated Receptor Subunits
The mutant subunits a1S204C, a1S205C, a1T206C, a1G207C,
a2S204C, a2S205C, a2T206C, a2G207C, a3S229C, a3S230C,
a3T231C, a5T208C, a5S209C, a5T210C, a6S203C, a6N204C
and a6T205C were prepared using the QuikChange
TM mutagen-
esis kit (Stratagene). For cell transfection, the cDNAs were
subcloned into the polylinker of pBC/CMV [36]. This expression
vector allows high-level expression of a foreign gene under control
of the cytomegalovirus promoter.
The Cysteine-reactive Compound
The synthesis of the cysteine-reactive compound 3-NCS (Fig. 1)
has been described before [32].
Transfection of GABAA Receptors in HEK293 Cells and
Membrane Preparation
cDNAs coding for the ax (x = 1, 2, 3, 6), b2, and c2S subunits
DNA (20 mg : 20 mg : 20 mg) per 9 cm diameter dish were
transfected in human embryonic kidney (HEK) 293 cells
(American Type of Culture Collection, MD, USA, CRL 1573)
using the calcium phosphate precipitation technique [37]. For a5
containing receptors b2 was replaced by b1. This resulted in higher
expression levels. Culturing of cells and membrane preparation
were done as described before [30].
Radioactive Ligand Binding Assay
The properties of the recombinant mutant receptors were only
estimated. For this affinity estimate, membranes were re-suspend-
ed in phosphate buffer using a Teflon homogenizer. They were
incubated in a total volume of 360 ml for 1 h on ice in the presence
of [3H]Ro15–1788 (78.6 Ci/mmol; PerkinElmer Life Sciences).
The final protein concentration was 0.1–1 mg of protein/ml.
Total binding was measured at 0.5 and 5 nM [3H]Ro15–1788.
Nonspecific binding was determined under the same condition but
in the presence of 100 mM unlabeled Ro15–1788 and amounted
to less than 10% of total binding, except for a2S206Cb2c2 and
a5T208Cb2c2 where it amounted to 10–17%. Expression levels of
a6b2c2 receptors were estimated with [
3H]Ro15–4513. Mem-
branes were collected by rapid vacuum filtration on GF/C filters.
After three washing steps (3 sec each) with 5 ml of phosphate
buffer, the filter-retained radioactivity was determined by liquid
scintillation counting.
Detection of a Covalent Reaction
As detailed in previous work [28,30,33] this procedure included
three steps: incubation of membranes expressing recombinant wild
type or mutant receptors with the reactive agent followed by
extensive washing of the membranes in order to remove non-
reacted compound and a radioactive ligand binding assay to
determine residual binding. No covalent reaction would result in
100% residual binding, and 100% covalent reaction would result
in 0% residual binding.
Figure 1. Chemical structures of diazepam, 3-NCS and Ro15–1788.
doi:10.1371/journal.pone.0042101.g001
Figure 2. Alignment of Loop C of the a subunits. The underlined
residues were individually mutated to cysteine. The bold residues react
covalently with 3-NCS. a4 was not investigated and is only shown for
comparison.
doi:10.1371/journal.pone.0042101.g002
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Briefly, the membranes were re-suspended in phosphate buffer
(100 mM KCl, 10 mM KH2PO4, 0.1 mM EDTA, pH 7.4) using
a Glass/Teflon homogenizer. 0.1–1.0 mg/mL of protein were
incubated in a total volume of 360 mL with either 10 mM
(determination of degree of covalent reaction) or several concen-
trations of 3-NCS for 30 min on ice. Membranes were collected
with rapid filtration on a round 7 mm diameter glass fiber filter
(GF/C; Whatman) that was placed on a round 24 mm diameter
glass fiber filter (GF/C; Whatman), both pre-washed with
phosphate buffer. The reaction of 3-NCS with the receptor was
stopped by washing of the filters six times with 5 mL phosphate
buffer, each. The small filters with the deposited membranes were
incubated in 0.12 mL phosphate buffer containing 5 nM
[3H]Ro15–1788. After 30 min the 7 mm filter was placed on a
24 mm filter and washed six times with 5 mL phosphate buffer
each. Radioactivity was determined by liquid scintillation count-
ing. Non-specific binding was determined in the presence of
100 mM Ro 15–1788. In control experiments, washing efficiency
was estimated by placing radioactivity on the small filter. More
than 99.95% of the radioactivity was removed (not shown).
Concentration response curves for 3-NCS were fitted with the
equation C(c) = Cmax/(1+(EC50/c)), where c is the concentration
of 3-NCS, EC50 the concentration of 3-NCS where half maximal
covalent reaction was observed, Cmax is the maximal extent of the
covalent reaction and C the measured extent of the covalent
reaction.
Expression of GABAA Receptors in Xenopus Oocytes
Capped cRNAs were synthesized (Ambion, Austin, TX, USA)
from the linearized plasmids with a cytomegalovirus promotor
(pCMVvectors) containing the different subunits, respectively. A
poly-A tail of about 400 residues was added to each transcript
using yeast poly- A polymerase (United States Biologicals,
Cleveland, OH, USA). The concentration of the cRNA was
quantified on a formaldehyde gel using Radiant Red stain (Bio-
Rad) for visualization of the RNA. Known concentrations of RNA
ladder (Invitrogen) were loaded as standard on the same gel.
cRNAs were precipitated in ethanol/isoamylalcohol 19: 1, the
dried pellet dissolved in water and stored at 280uC. cRNA
mixtures were prepared from these stock solutions and stored at
280uC. Xenopus laevis oocytes were prepared, injected and
defolliculated as described previously [38,39]. They were injected
with 50 nL of the cRNA solution containing wild type or mutated
a1 or a2, a3, a5, a6 and wild type b2 and c2 subunits at a
concentration of 10 nM : 10 nM : 50 nM [40] and then incubated
in modified Barth’s solution at +18uC for at least 24 h before the
measurements.
Functional Characterization of the GABAA Receptors
Currents were measured using a modified two-electrode voltage
clamp amplifier Oocyte clamp OC-725 (Warner Instruments) in
combination with a XY-recorder (90% response time 0.1s) or
digitized at 100 Hz using a PowerLab 2/20 (AD Instruments)
using the computer programs Chart (ADInstruments GmbH,
Spechbach, Germany). Tests with a model oocyte were performed
to ensure linearity in the larger current range. The response was
linear up to 15 mA.
Electrophysiological experiments were performed by using the
two-electrode voltage clamp method at a holding potential of
280 mV. The perfusion medium contained 90 mM NaCl, 1 mM
KCl, 1 mM MgCl2, 1 mM CaCl2, and 5 mM Na-HEPES (pH
7.4) and was applied by gravity flow 6 ml/min. The perfusion
medium was applied through a glass capillary with an inner
diameter of 1.35 mm, the mouth of which was placed about
0.4 mm from the surface of the oocyte. Allosteric modulation via
the benzodiazepine site was measured at a GABA concentration
eliciting 2–5% of the maximal GABA current amplitude. GABA
was applied for 20 s alone or in combination with allosteric
compound. 6 ml of the covalent reacting compound was applied
to the oocyte and incubated for 3 min while stopping the flow of
the perfusion medium. Modulation of GABA currents was
expressed as (I(modulator + GABA)/IGABA –1) * 100%. The perfusion
system was cleaned between drug applications by washing with
DMSO to avoid contamination.
Results
We wanted to derive information on part of the benzodiazepine
binding pockets in different GABAA receptor isoforms. For this
purpose, we characterized the covalent interaction of a benzodi-
azepine-like compound with axb1/2c2 (x = 1, 2, 3, 5, 6) receptors
containing a cysteine mutation in residues a1S204C, a1S205C and
a1T206C and homologous positions in a2, a3, a5 and a6. The b2
subunit was used throughout except for expression of a5
containing receptors in HEK-cells where b1 was used instead to
achieve higher expression levels. a1G207C and the homologous
mutation a2G207C were also prepared. These mutated subunits
did not confer to the expressed receptors high affinity [3H]Ro 15–
1788 or [3H]flunitrazepam binding nor functional modulation by
diazepam (not shown). This indicates that mutation in this position
disrupts the binding site for benzodiazepines.
The Cysteine Reactive Compound
We used a modified nitrazepam molecule carrying a cysteine
reactive isothiocyanate substituent at the C-3 carbon (3-NCS;
Fig. 1). 3-NCS was able to displace [3H]Ro15–1788 or [3H]fluni-
trazepam from wild-type a1b2c2 receptors. The Ki values were
340616 nM and 240655 nM [32], respectively. The Ki values
for displacement of [3H]Ro 15–1788 by 3-NCS in a2b2c2 were
15506250 nM (n = 3) and in a5b1c2 receptors 984061480 nM
(n = 3). The determination of Ki values was based on the Kd values
of 2.160.5 nM and 1.561.2 nM, respectively. The covalent
reaction of 3-NCS with a1mb2c2 (m = S205C, T206C) receptor at
the binding and functional level has previously been described
[32].
Binding Properties of the GABAA Receptor Carrying a
Cysteine Point Mutation
The homologous residues to a1S204, a1S205 and a1T206 in a2,
a3, a5 and a6 were mutated individually to cysteine. a1 and a2
were expressed in combination with b2 and c2 subunits, a5 for
reasons mentioned above together with b1 and c2 subunits. All
these mutated amb2c2 receptors bound [
3H]Ro 15–1788 with an
estimated affinity between 0.08 and 7.5 nM (data not shown). No
specific binding was detected in a 3 containing receptors (data not
shown). a6T205Cb2c2 bound [
3H]Ro15–4513 with an estimated
affinity 4 nM.
Covalent Reaction of 3-NCS at the Binding Level
First we tested reactivity of 3-NCS using a radioactive ligand
binding assay. 3-NCS is expected to first occupy its binding site
reversibly. Upon proper apposition of the –SH group of the
cysteine from the mutated receptors with the –C atom of the NCS
group from the 3-NCS compound, this is followed by covalent
reaction. This reaction was determined at 10 mM concentration of
3-NCS. Preliminary experiments showed that at this concentration
and at 1 mM 3-NCS, covalent reaction was reaching a maximum
within 15 sec (not shown). Covalent reaction did not reach
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completion. This observation was made before and has been
interpreted to indicate covalent reaction at a low affinity
benzodiazepine binding site at the a/b subunit interface, which
prevents covalent reaction on the classical benzodiazepine binding
site [33]. Alternatively or in addition, the reactive compound may
be consumed in non-specific reactions. Non-covalently reacted
compound was removed by filtration (see methods). A covalent
reaction of 3-NCS with a mutated cysteine residue is expected to
prevent reversible binding of the [3H]Ro15–1788. If no covalent
reaction occurs, the binding site should still be available for
reversible binding. a5 containing receptors were expressed
together with b1 instead of b2. a3 containing receptors did not
express in HEK293-cells. As a6 subunit containing receptors do
not bind [3H]Ro15–1788 with high affinity, we used [3H]Ro15–
4513 instead.
Figure 3 compares the percentage of covalent reaction, in
mutated a1, a2, a5 and a6 containing receptors. For the a1b2c2
receptor isoform cysteine mutation in residue S205 and T206
resulted in covalent reaction, while S204C did not covalently
react with 3-NCS [32]. For a2b2c2 receptor isoform the cysteine
mutated residues homologous to a1S204, a1S205 and a1T206
showed covalent reaction amounting to 52%68% (n = 3),
39%68% (n = 3) and 54%61% (n = 3). For a5b1c2 receptors
the cysteine mutated receptors homologous to a1S204, a1S205
and a1T206 reacted covalently amounting to 26%65% (n = 3),
54%68% (n = 3) and 73%62% (n = 3). In the a6b2c2 receptor
isoform only the cysteine mutation homologous to a1T206
reacted covalently with 3-NCS amounting to 68% 66% (n = 3).
Concentration Dependence of the Covalent Reaction
We next investigated the concentration dependence of the
covalent reaction. Mutated receptors were exposed for 30 min to
different concentrations of 3-NCS. Figure 4 documents such a
concentration dependence in a6T205Cb2c2 receptors. The
concentration dependence was also determined in mutated
a1S204Cb2c2, a1S205Cb2c2, a1T206Cb2c2 and homologous
mutations in a2, a5 and a6 containing receptors. Table 1
documents the calculated EC50 values of the covalent reaction,
which are between 0.08 mM and 6.6 mM. For a1S204Cb2c2,
a6S203Cb2c2, a6N204Cb2c2 the EC50 values could not be
determined because we could not detect covalent reaction with
3-NCS.
Residue 206 is unique in that all the investigated subunit
isoforms do show covalent reaction. In each case the absolute level
of the reaction is relatively high (Fig. 3). It should be noted that
residue 206 in the a1 subunit and homologous residues in a2 and
a5 show a very high apparent affinity in the reaction with 3-NCS
while the corresponding residue in a6 shows a lower apparent
affinity (F-test; p,0.01). In a1, a2 and a5, the residue identical to
or homologous to residue 206 in the a1 subunit has a lower EC50
than residue 205 in the corresponding a subunit (F-test; p,0.01).
Residue 205 in the a1 subunit shows a higher apparent affinity in
the reaction with 3-NCS than the homologous residue in a2 (F-
test; p,0.02).
Irreversible Reaction of 3-NCS at the Functional Level
We also studied the covalent reaction at the functional level. All
wild type receptors failed to show any changes in the current
amplitude elicited by GABA, while some mutant receptors did. An
example of this experiment is shown in Figure 5a for the
Figure 3. Covalent reaction at the binding level. Extent of
covalent reaction of 3-NCS at a1S204Cb2c2, a1S205Cb2c2, a1T206Cb2c2
mutant GABAA receptors and homologous receptors formed with a2,
a3, and a6. a5 was expressed together with b1 and c2 subunits for
reasons mentioned in the results section. Receptors were expressed in
HEK-293 cells, membranes harvested and exposed to 10 mM 3-NCS.
After incubation, the residual 3-NCS was removed by filtration.
[3H]Ro15–1788 was used as radioactive ligand to determine the residual
binding. Covalent binding is expressed as 100% minus % residual
binding. Data are shown as mean 6SD for three experiments each
(triplicates of each point in each experiment).
doi:10.1371/journal.pone.0042101.g003
Figure 4. Concentration dependence at the binding level.
Concentration dependence of the covalent reaction of the 3-NCS at
a6T205Cb2c2 mutant GABAA receptors. Extent of covalent reaction was
determined at different concentrations of 3-NCS as indicated below
Fig. 3. Data are shown as mean 6SD for three experiments each
(triplicates of each point in each experiment).
doi:10.1371/journal.pone.0042101.g004
On the Benzodiazepine Binding Site
PLoS ONE | www.plosone.org 4 July 2012 | Volume 7 | Issue 7 | e42101
a1S205Cb2c2 mutant receptor. 3-NCS led to an irreversible
increase in the current amplitude and the relative stimulation by
diazepam was smaller than observed in naı¨ve oocytes (Fig. 5b). We
interpret this as evidence for a covalent reaction. Fig. 5c shows the
same experiment at the mutant receptor a1T204Cb2c2. 3-NCS
did not increase the current amplitude and diazepam stimulated to
the same extent as in naı¨ve oocytes (Fig. 5d). Clearly, this mutant
receptor did not show any covalent reaction. As a6 containing
receptors did not respond to diazepam, we used 1 mM abercarnil
instead.
Exposure of mutant receptors a1S205Cb2c2, a1T206Cb2c2,
a2T205Cb2c2 (mutation homologous to a1S205), a2T206Cb2c2
(a1T206), a3T231Cb2c2 (a1T206), a5T208Cb2c2 (a1S204),
a5T209Cb2c2 (a1S205), and possibly a3S230Cb2c2 (a1S205)
and a6T205Cb2c2 (a1T206), to 3-NCS resulted in an irrevers-
ible positive allosteric modulation (Table 2) indicating a covalent
reaction, the adduct acting as a positive allosteric modulator. If
only a fraction of the receptors react with 3-NCS, diazepam is
expected to stimulate the remaining receptors. If 3-NCS has a
similar allosteric effect as diazepam the combined stimulations
of 3-NCS and diazepam should be the same as stimulation by
diazepam alone. This is the case for most mutated receptors
studied. Exceptions are a1T206Cb2c2, a3T231Cb2c2 (homolo-
gous to a1T206), a5T208Cb2c2 (a1S204) and a5T210Cb2c2
(a1T206). In the last two cases, results may be explained if 3-
NCS acts at these mutated receptors as a partial modulator and
an antagonist, respectively, at the benzodiazepine site. In the
first two cases combined stimulation by 3-NCS and diazepam is
larger than expected from diazepam alone. The latter seems in
both cases reduced by the mutation for unknown reasons. We
can only hypothesize that covalent reaction with 3-NCS at the
a/b subunit interface may allosterically stimulate the reaction to
diazepam. It is interesting to note that at the functional level
the identical residues were identified to react covalently as at
the binding level. This in spite of the use of Ro15–1788 to
detect covalent reaction at the binding level and the use of
diazepam at the functional level. The only exception is
a2S204C. We have no explanation for this discrepancy.
Differences in the experimental conditions used in binding
and functional experiments (total lipid content, lipid composition
and temperature) may be responsible.
Discussion
The most common GABAA receptors contain two identical or
different a subunits [6]. Receptors containing different a subunit
isoforms adjacent to the c subunit mediate different effects of
classical benzodiazepines. a1, a2, a3 or a5 are required in this
position for the action of classical benzodiazepines. In order to be
able to rationally design receptor subtype specific drugs more
knowledge on the difference of the interaction of different receptor
subtypes with classical benzodiazepines is required.
We aimed at finding differences or similarities in the shape of
the benzodiazepine binding site in different receptor isoforms.
We used the proximity-accelerated chemical coupling reaction
at the binding and functional level. A Cysteine-mutated receptor
is combined with a chemical modified cysteine reactive binding
site ligand. Indentification of a covalent reaction implies
apposition of the –S atom of cysteine and the reactive –C
atom of the ligand [41]. After previous work in the a1H101
region [33], where we found that a NCS group introduced into
diazepam at the –Cl position interacts subtly different with a1,
a2, a3 and a6, but only very weakly with a5, we concentrated
here on the C atom adjacent to the keto group in diazepam.
We have previously shown that a1S205Cb2c2 and a1T206Cb2c2
receptors but not a1S204Cb2c2 receptors interact covalently
with 3-NCS [32]. Now homologous mutations were introduced
into other a subunit isoforms.
We studied the covalent reaction at the level of radioactive
ligand binding at receptors expressed in transfected HEK 293 cells
and at the functional level characterizing chloride current
mediated by receptors expressed in Xenopus oocytes. In general,
we found very good agreement of the results obtained by the two
strategies. In case covalent reaction occurs not in the binding
pocket, but on the access pathway of 3-NCS, we would not expect
an allosteric modulation of the corresponding receptor. Thus the
agreement between the strategies can be taken as evidence for a
reaction in the binding pocket.
In the following we discuss in sequence our observations for the
position homologous to a1S204, to a1S205, to a1T206 and to
a1G207 in axb2c2 (x = 1, 2, 3, 5, 6) receptors.
Position homologous to a1S204: At the binding level, mutated
a2b2c2 and a5b1c2 showed covalent reaction, while a1b2c2 and
a6b2c2 did not. At the functional level, exclusively mutated a5b2c2
showed covalent reaction. We have no explanation for the
discrepancy concerning a2b2c2. Possibly, 3-NCS acts as an
antagonist here and covalent reaction at the a/b subunit interface
promotes stimulation by diazepam. a3b2c2 could not be expressed
at sufficient extent to determine reaction levels.
Position homologous to a1S205: At the binding level, mutated
a1b2c2, a2b2c2 and a5b1c2 showed covalent reaction, while
mutated a6b2c2 did not. At the functional level, the same result
was obtained. In addition, a3b2c2 might have reacted covalently at
the functional level, but reaction was at the threshold for
significance.
Position homologous to a1T206: At the binding level, all
mutated receptors investigated a1b2c2, a2b2c2, a5b1c2 and a6b2c2
showed covalent reaction. At the functional level, the same result
Table 1. Concentration dependence of the covalent reaction
at mutant receptors at the binding level.
mutated receptor mutation homologous to EC50 (mM)
a1S204Cb2c2 n.r.
a1S205Cb2c2 0.6360.18
a1T206Cb2c2 0.08260.028
a2S204Cb2c2 a1S204C 3.262.3
a2S205Cb2c2 a1S205C 6.665.4
a2T206Cb2c2 a1S206C 0.1960.056
a5T208Cb1c2 a1S204C 0.3960.21
a5S209Cb1c2 a1S205C 4.162.2
a5T210Cb1c2 a1S206C 0.4560.15
a6S203Cb2c2 a1S204C n.r.
a
a6N204Cb2c2 a1S205C n.r.
a
a6T205Cb2c2 a1S206C 5.460.80
a
Left column: mutated receptors. Middle column: homology of the mutations to
a1. Right column EC50 is given as mean 6SD for three to four experiments
where each point in the dose-response curve was determined in triplicates. The
receptors were exposed to increasing concentrations of 3-NCS compound for
30 min on ice and extensively washed. Residual binding was determined using
[3H]Ro15–1788 as radioactive ligand and converted to percentage of binding
sites covalently reacted. All wild type receptors showed no covalent reaction.
n.r.: no covalent reaction.
a[3H]15–4513 was used as a radioactive ligand.
doi:10.1371/journal.pone.0042101.t001
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Figure 5. Covalent reaction at the functional level. Exposure of mutated a1S205Cb2c2 receptors to 3-NCS results in a covalent reaction. a)
Receptors were exposed twice to 0.5 mM GABA followed by a washing period and a 3 min incubation in 10 mM 3-NCS. After this treatment GABA was
applied twice with a 3 min interval. In some experiments GABA was applied up to six times. Thus, the current elicited by GABA was stimulated
irreversibly. Application of 0.5 mM GABA in combination with 1 mM diazepam results in a further stimulation of the partially irreversibly reacted
receptors that was smaller than that seen upon b) direct exposure to diazepam in independent experiments. Exposure of a1T204Cb2c2 receptors 3-
NCS does not result in a covalent reaction. c) Receptors were exposed twice to 0.5 mM GABA followed by a 3 min incubation in 10 mM 3-NCS.
Application of 0.5 mM GABA in combination with 1 mM diazepam results in stimulation similar to the stimulation seen in an oocyte that had not been
previously exposed to 3-NCS (Fig. 4d).
doi:10.1371/journal.pone.0042101.g005
Table 2. Covalent reaction at the functional level.
Mutated receptor Mutation homolo-gous to DZ n 3-NCS p 3-NCS +DZ n
a1S204Cb2c2
+ 12669 3 464 n.s. 115634 3
a1S205Cb2c2 11367 3 60643 ,0.03 131632 3
a1T206Cb2c2 82618 6 119651 ,0.01 204662 4
a2S204Cb2c2
+ a1S204C 215642 3 1610 n.s. 218630 3
a2S205Cb2c2 a1S205C 191653 3 35610 ,0.01 177625 3
a2T206Cb2c2 a1S206C 14868 3 53629 ,0.01 168654 3
a3S229Cb2c2 a1S204C l.e. l.e. l.e.
a3S230Cb2c2 a1S205C 149644 3 15611 n.s. 158644 3
a3T231Cb2c2 a1S206C 88645 3 28616 ,0.03 16568 3
a5T208Cb2c2 a1S204C 129638 7 23618 ,0.05 83625 5
a5S209Cb2c2 a1S205C 10363 3 46617 ,0.01 140620 3
a5T210Cb2c2 a1S206C 82614 3 1065 n.s. 4768 3
a6S203Cb2c2
+ a1S204C 50620* 3 062 n.s. 57621* 3
a6N204Cb2c2
+ a1S205C 70640* 3 2466 n.s. 71640* 3
a6T205Cb2c2 a1S206C 4866* 3 1468 ,0.05 58621* 3
Mutated GABAA receptors were expressed in Xenopus oocytes. Allosteric stimulation by 1 mM diazepam was determined (column labelled DZ (diazepam)) at EC2–5 for
GABA. Data are given as % allosteric modulation. In independent experiments oocytes were exposed to GABA followed by 10 mM 3-NCS and after removing non-
covalently reacted 3-NCS, allosteric stimulation was determined (column labelled 3-NCS). Subsequently the same oocyte was exposed to 1 mM diazepam (column
labelled 3-NCS + diazepam) and allosteric stimulation was determined as compared to the initial application of GABA. *1mM Abecarnil was used. l.e. low expression,
expressed currents were too small for measurement of covalent effects. p was determined with the one-way ANOVA followed by a post-hoc Dunnett’s test where the
non-responsive receptors indicated with (+) served as one of the samples (mean 6 mean SD, 0.2565.5, n = 4). Data are given as mean 6SD.
doi:10.1371/journal.pone.0042101.t002
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was obtained except for possibly a6b2c2, which is at the threshold
for significance. In addition, mutated a3b2c2 reacted covalently.
Position homologous to a1G207: At the binding and at the
functional level mutated a1b2c2 and a2b2c2 receptors were missing
the benzodiazepine binding site. In functional experiments
currents induced by GABA were not affected by the mutations.
All other receptor isoforms were not tested.
In summary there is evidence for covalent reaction of the a1
subunit in residues 205 and 206; of the a2 subunit in residues 204,
205 and 206; of the a3 subunit at least in residue 206 and possibly
205; of the a5 subunit in residues 204, 205 and 206; and of the a6
subunit exclusively in residue 206. The residues highlighted in
bold face react with a high apparent affinity. It is interesting to
note that the residue homologous to 206 reacts covalently in all
receptors. Unexpectedly, the a2 subunit showed a similar reactivity
pattern as the a5 subunit.
These observations should be combined with data on another
region of the benzodiazepine binding pocket. The region of the –
Cl atom in diazepam has previously been investigated in different
GABAA receptor isoforms [33]. A molecule made reactive in this
position interacted best with a6 containing receptors and very little
with a5 containing receptors while the variants with a1, a2, and a3
were intermediate.
The combined set of data is visualized in Fig. 6. The size of the
lettering of the residues correlates qualitatively with the affinity of
the covalent reaction. Our observations will help in modelling of
the benzodiazepine binding pocket in different a subunit
containing isoforms of the GABAA receptor.
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